141 related articles for article (PubMed ID: 3011236)
21. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
22. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Ohkura H; Suemasu K
Cancer; 1986 Apr; 57(7):1318-23. PubMed ID: 3004689
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
25. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
[TBL] [Abstract][Full Text] [Related]
26. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
van der Gaast A; van Putten WL; Oosterom R; Cozijnsen M; Hoekstra R; Splinter TA
Br J Cancer; 1991 Aug; 64(2):369-72. PubMed ID: 1654076
[TBL] [Abstract][Full Text] [Related]
28. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
29. Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
Fischbach W; Schwarz-Wallrauch C; Jany B
Cancer; 1989 Mar; 63(6):1143-9. PubMed ID: 2537135
[TBL] [Abstract][Full Text] [Related]
30. Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1.
Laberge F; Fritsche HA; Umsawasdi T; Carr DT; Welch S; Murphy WK; Chiuten DF; Dhingra HM; Farha P; Spitzer G
Cancer; 1987 Jun; 59(12):2047-52. PubMed ID: 3032400
[TBL] [Abstract][Full Text] [Related]
31. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
32. Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia.
Källander CF; Simonsson B; Hagberg H; Gronowitz JS
Cancer; 1984 Dec; 54(11):2450-5. PubMed ID: 6498737
[TBL] [Abstract][Full Text] [Related]
33. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma.
Simonsson B; Brenning G; Källander C; Ahre A
Eur J Clin Invest; 1987 Aug; 17(4):336-9. PubMed ID: 3117570
[TBL] [Abstract][Full Text] [Related]
36. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
[TBL] [Abstract][Full Text] [Related]
37. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].
Załeska M; Szturmowicz M; Zych J; Roszkowska-Sliz B; Demkow U; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2010; 78(1):14-20. PubMed ID: 20162514
[TBL] [Abstract][Full Text] [Related]
38. Lactate dehydrogenase values and bone scans as predictors of bone marrow involvement in small-cell lung cancer.
Hamrick RM; Murgo AJ
Arch Intern Med; 1987 Jun; 147(6):1070-1. PubMed ID: 3036032
[TBL] [Abstract][Full Text] [Related]
39. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1988 Dec; 58(6):805-7. PubMed ID: 2852029
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.
Sculier JP; Feld R; Evans WK; Shepherd FA; DeBoer G; Malkin DG; Malkin A
J Clin Oncol; 1985 Oct; 3(10):1349-54. PubMed ID: 2995598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]